BridgeMD
Compares treatment options for Diabetic Macular Edema
Official title CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
ClinicalTrials.gov ID: NCT07449923
What this study is testing
What is EYP-1901?
EYP-1901 is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for diabetic macular edema.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept.
- Phase 3: a large, late-stage study
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Previously treated or treatment naïve patients with a documented diagnosis of macular edema associated with diabetic retinopathy (DR) in the study...
- Best-corrected visual acuity (BCVA) Early Treatment Diabetic Retinopathy Study (ETDRS) letter score of 35 letters (20/200 Snellen equivalent) to 78...
- For previously treated participants: at least 1 injection of anti-VEGF in the past 12 months, the most recent anti-VEGF treatment for DME must not...
You likely can't join if
- BCVA using ETDRS charts \<30 letters (20/250 Snellen equivalent) in the fellow eye.
The study team makes the final eligibility decision.
Where it's taking place
- Gilbert, Arizona, United States
- Phoenix, Arizona, United States
- Scottsdale, Arizona, United States
- Beverly Hills, California, United States
- Fullerton, California, United States
- Long Beach, California, United States
- Modesto, California, United States
- Oakland, California, United States
- Redlands, California, United States
- Walnut Creek, California, United States
- Arvada, Colorado, United States
- Danbury, Connecticut, United States
- Greenwich, Connecticut, United States
- Waterford, Connecticut, United States
- Fort Lauderdale, Florida, United States
- Pensacola, Florida, United States
- Plantation, Florida, United States
- South Miami, Florida, United States
- St. Petersburg, Florida, United States
- Tampa, Florida, United States
+ 38 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Gilbert, Arizona, United States; Phoenix, Arizona, United States; Scottsdale, Arizona, United States; Beverly Hills, California, United States; Fullerton, California, United States; Long Beach, California, United States and 52 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.